Biomonitoring study needs careful interpretation, chemistry industry says
Thanks to advances in analytical chemistry, researchers are able to measure extraordinarily low levels of natural and man-made substances in human fluids and tissues - often as little as one part per billion (a single drop in an Olympic-sized swimming pool). Of course, health researchers know that the simple presence of an environmental chemical in a person's body does not mean that it will cause health effects or disease.
Biomonitoring provides a "snapshot" of the substances present in the body at a single point in time, but it cannot explain where a detected substance came from, when the exposure occurred, or whether there will be any health effects. For those reasons, the Chemistry Industry Association of Canada believes there must be a risk-based process for interpreting biomonitoring results, and for using such data for regulatory purposes or other decision-making.
Most read news
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.